Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacotherapy for bronchiectasis.

Michael R Loebinger1, Robert Wilson

  • 1Royal Brompton Hospital, Host Defence Unit, Fulham Road, London, SW3 6NP, UK.

Expert Opinion on Pharmacotherapy
|November 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registry.

American journal of respiratory and critical care medicine·2026
Same author

Maximizing treatment response in patients with neuropathic-subtype postural orthostatic tachycardia syndrome.

Frontiers in neurology·2026
Same author

Mucoactive therapies and the European Respiratory Society guideline for adult bronchiectasis: what now after the CLEAR trial?

The European respiratory journal·2026
Same author

Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries.

The Lancet. Respiratory medicine·2026
Same author

The Reward Positivity Tracks Positive Reward Prediction Errors From Feedback to Cues During Reinforcement Learning.

Psychophysiology·2026
Same author

Gaboxadol increases resting theta and alpha power without affecting evoked responses in fragile X syndrome in a home-based setting.

Journal of neurodevelopmental disorders·2026
Same journal

Pharmacotherapeutic interventions for pediatric ulcerative colitis.

Expert opinion on pharmacotherapy·2026
Same journal

The rise and fall of TRPV1-targeted analgesia in osteoarthritis: a critical appraisal.

Expert opinion on pharmacotherapy·2026
Same journal

Dopamine transporter and beyond: evolving targets and combination strategies in stimulant use disorder.

Expert opinion on pharmacotherapy·2026
Same journal

GnRH antagonists for the treatment of fibroids and adenomyosis, current evidence and future perspectives.

Expert opinion on pharmacotherapy·2026
Same journal

Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia.

Expert opinion on pharmacotherapy·2026
Same journal

CURRENT ADVANCES IN PHARMACOTHERAPEUTIC STRATEGIES FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS.

Expert opinion on pharmacotherapy·2026
See all related articles

Bronchiectasis management focuses on identifying causes and preventing infections through physiotherapy and antibiotics. Evidence for treatments is limited, often relying on expert opinion for this chronic lung disease.

Area of Science:

  • Pulmonology
  • Respiratory Medicine

Background:

  • Bronchiectasis is a chronic lung condition marked by persistent cough, sputum, and recurrent infections.
  • Current management strategies are often based on expert consensus due to limited high-quality randomized controlled trials.

Purpose of the Study:

  • To discuss the management of bronchiectasis.
  • To review the pathophysiological processes underlying bronchiectasis.
  • To examine the evidence supporting current treatment approaches.

Main Methods:

  • Literature review focusing on bronchiectasis pathophysiology and management.
  • Analysis of existing evidence, including expert opinion and extrapolated data.
  • Discussion of treatment strategies for prevention of exacerbations.

Related Experiment Videos

Main Results:

  • Management involves identifying underlying causes and preventing infectious exacerbations.
  • Physiotherapy and judicious antibiotic use are key components of care.
  • Evidence base for many treatments is derived from expert opinion rather than robust trials.

Conclusions:

  • Effective bronchiectasis management requires understanding its pathophysiology.
  • A comprehensive approach combining etiological investigation and exacerbation prevention is crucial.
  • Further high-quality research is needed to strengthen the evidence base for treatment.